Systemic Organ Communication in STEMI (SYSTEMI)
Sponsor: Heinrich-Heine University, Duesseldorf
This observational or N/A phase trial investigates ST-segment Elevation Myocardial Infarction (STEMI) and is currently actively recruiting participants. Heinrich-Heine University, Duesseldorf leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
11 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
Status: Unknown → Recruiting
-
Sep 2025 — Feb 2026 [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jun 2024 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 6 earlier versions
-
Jun 2022 — Jun 2024 [monthly]
Recruiting
-
Dec 2021 — Jun 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Sep 2019 — Nov 2020 [monthly]
Recruiting
-
Jun 2018 — Sep 2019 [monthly]
Recruiting
First recorded
Oct 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Heinrich-Heine University, Duesseldorf
For direct contact, visit the study record on ClinicalTrials.gov .